Savara Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for rare respiratory diseases

The company is dedicated to improving the lives of patients with unmet medical needs by harnessing its expertise in inhalation therapy and drug delivery. Savara's ambitious pipeline includes candidates aimed at addressing conditions such as pulmonary diseases, and its research is driven by a commitment to scientific excellence and patient outcomes. Through collaboration and cutting-edge technology, Savara strives to bring new and effective therapies to market, ultimately enhancing the quality of life for those affected by respiratory ailments.